Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1161-1180 of 2,731 trials

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

NCT04649255

To evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral vasculature.

Peripheral Arterial Hemorrhage

BlackSwan Vascular, Inc.113 participantsStarted Apr 2021

Irvine, California, United States • Los Angeles, California, United States • Miami, Florida, United States +6 more locations

COMPLETEDPhase 1< 1 mile

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT04539470

This is a Phase Ib, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of Efmarodocokin Alfa and to make a preliminary assessment of activity of Efmarodocokin Alfa in combination with standard-of-care (SOC) in the prevention of acute graft-versus-host disease (aGVHD) in participants undergoing allogeneic hematopoietic stem cell transplantation (HSCT).

Acute Graft-versus-host Disease

Genentech, Inc.18 participantsStarted Nov 2020

Duarte, California, United States • Los Angeles, California, United States • Miami, Florida, United States +5 more locations

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Rheumatoid Arthritis Trials in Other Cities

Safety and Effectiveness Study of the Zenflow Spring System

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Other Conditions in Los Angeles